Clinical Trial Update: HYDRAFIL-D: HYDRogel Augmentation For Intervertebral Lumbar Discs [NA]

View source ↗

Summary

Clinical trial NCT06011551 evaluates HYDRAFIL-D, a HYDRogel augmentation for intervertebral lumbar discs developed by ReGelTec, Inc., and is currently recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Degenerative Disc Disease

Drugs mentioned

• HYDRAFIL-D

Snippet

Sponsor: ReGelTec, Inc. | Conditions: Degenerative Disc Disease (DDD) | NA | Status: RECRUITING